Sign in Subscribe
Scientists

Protein C Inhibitor Regulates Cathepsin L Activity and Tumor Cell Migration

Strategic Insights

— 1 min read

Researchers from Johns Hopkins University have discovered that protein C inhibitor (PCI) regulates cathepsin L activity and cell-mediated tumor cell migration. According to the study, PCI inhibits cathepsin L with an inhibition rate of 3.0x10^5 M^-1 s^-1, suggesting a crucial role in hemostasis, cardiovascular, and metastatic diseases.

The study found that PCI inhibits cathepsin L in human breast cancer cells, reducing their migration and potentially inhibiting cancer progression. The researchers also discovered that downregulating cathepsin L using a specific inhibitor or siRNA technology reduces tumor cell migration. This study provides new insights into the role of protein C inhibitor in regulating cathepsin L activity and tumor cell migration.

Key Takeaways:

  • Protein C inhibitor (PCI) inhibits cathepsin L activity with an inhibition rate of 3.0x10^5 M^-1 s^-1.
  • PCI reduces tumor cell migration in human breast cancer cells by inhibiting cathepsin L.
  • Downregulating cathepsin L using a specific inhibitor or siRNA technology reduces tumor cell migration.
  • Inhibiting cathepsin L by serpins like PCI may be a new pathway of regulating hemostasis, cardiovascular, and metastatic diseases.
  • The study provides new insights into the role of protein C inhibitor in regulating cathepsin L activity and tumor cell migration.
  • The research was conducted by Y.M. Fortenberry and colleagues from Johns Hopkins University, Department of Pediatric Hematology.

Statistics:

  • Inhibition rate of PCI against cathepsin L: 3.0x10^5 M^-1 s^-1.
  • Number of human breast cancer cells used in the study: MDA-MB-231.
  • Percentage decrease in tumor cell migration in the presence of wild-type PCI: significantly decreased.
  • Percentage decrease in tumor cell migration in the presence of PCI P1 mutant: similar to wild-type PCI.

Sources:

  • Fortenberry, Y.M., et al. (2010). Protein C inhibitor regulates both cathepsin L activity and cell-mediated tumor cell migration. Biochimica Et Biophysica Acta, 1800(6), 580-590.
  • Note: The study was published in Biochimica Et Biophysica Acta and was conducted by researchers from Johns Hopkins University, Department of Pediatric Hematology.

Read more